Gyre Therapeutics, Inc. (GYRE) dividend history
GYRENasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 6, 2026Score 11/3018% below fair value
$4.34−0.22 (-4.82%)
Close on Nov 18, 2026Market cap $483.95MP/E –Yield –
Dividends
Dividend declared per share by fiscal year, adjusted for stock splits
Per share, FY2025
–
Consecutive increases
0 years
Not raised last year
Five-year growth
–
Per year, per share
Payout ratio, FY2025
–
Dividends paid ÷ net income
Dividend payments
Every dividend Gyre Therapeutics has paid, newest first. Shares held at the close of the last day with dividend receive it; shares bought on the ex-dividend date or later do not.
| Ex-dividend | Last day to buy | Record | Payable | Declared | Per share | Source |
|---|---|---|---|---|---|---|
| Jan 13, 2023 | Jan 12, 2023 | Jan 5, 2023 | Jan 12, 2023 | Dec 26, 2022 | $0.24$3.60 split-adj. | 8-K |
| Sep 21, 2022 | Sep 20, 2022 | Sep 6, 2022 | Sep 20, 2022 | Aug 24, 2022 | $1.43$21.45 split-adj. | Release |
| Aug 20, 2015 | Aug 19, 2015 | Aug 14, 2015 | Aug 19, 2015 | Aug 4, 2015 | Irregular$1.6492$2597.49 split-adj. | 10-Q |
Per share as declared at the time; the split-adjusted figure is on today's share count. Source document: the dividend announcement filed with the SEC (press release or 8-K) where one exists, otherwise the quarterly or annual report covering the declaration.
By fiscal year
Dividend per share, cash paid and payout ratio from annual filings
| Fiscal year | Per share | Change | Cash paid | Payout ratio |
|---|---|---|---|---|
| FY2025 | – | – | – | – |
| FY2024 | – | – | – | – |
| FY2023 | – | – | – | – |
| FY2022 | $1.43 | – | $45.03M | 1043.8% |
See a number that looks wrong?